De- and resensitization of protease-activated receptor-1 (PAR-1) in rat astrocytes

被引:0
|
作者
Ubl, JJ
Sergeeva, M
Reiser, G
机构
[1] Otto Von Guericke Univ, Inst Neurobiochem, Magdeburg, Germany
[2] Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:S73 / S73
页数:1
相关论文
共 50 条
  • [41] Pharmacodynamics and pharmacokinetics of a novel protease-activated receptor (PAR-1) antagonist SCH 530348
    Kosoglou, T
    Reyderman, L
    Fales, RR
    Yang, B
    Keller, R
    Shah, A
    Maxwell, SE
    Veltri, EP
    Cutler, DL
    CIRCULATION, 2005, 112 (17) : U80 - U80
  • [42] In vivo and in vitro effect of a new thrombin protease-activated receptor (PAR-1) antagonist
    Dumas, M.
    Nadal-Wollbold, F.
    Grelac, F.
    Aiach, M.
    Le Grand, B.
    Gaussem, P.
    Bachelot-Loza, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 86 - 86
  • [43] SCH 530348 Is a Novel Oral Antiplatelet Agent Selective for Protease-Activated Receptor-1 (PAR-1) Receptor Subtype Without Partial Agonist Activity
    Chintala, Madhu
    Kurowski, Stan
    Zhai, Ying
    Lachowicz, Jean
    FASEB JOURNAL, 2009, 23
  • [44] Doxorubicin-induced Cardiac and Hepatic Toxicity is Mediated by Protease-activated Receptor 1 (PAR-1)
    Antoniak, Silvio
    Pawlinski, Rafal
    Mackman, Nigel
    CIRCULATION, 2010, 122 (21)
  • [45] Autoimmune Targeting of Protease Activated Receptor-1 (PAR-1) Deregulates VEGF and Disturbs Neoangiogenesis.
    Catar, R.
    Schramm, I.
    Simon, M.
    Wischnewski, O.
    Philippe, A.
    Kusch, A.
    Dragun, D.
    TRANSPLANTATION, 2014, 98 : 382 - 382
  • [46] Protease-activated receptor 1 (PAR-1) knock-out protects against liver fibrosis
    Rullier, Anne
    Gillibert-Duplantier, Jennifer
    Cubel, Gaelle
    Capdepont, Maylis
    Dugot-Senant, Nathalie
    Petibois, Cyril
    Costet, Pierre
    Rosenbaum, Jean
    HEPATOLOGY, 2006, 44 (04) : 249A - 249A
  • [47] Primary rat lung fibroblasts express functional protease activated receptor-1 (PAR-1) and respond to the profibrotic effects of thrombin
    Howell, DCJ
    Dunscombe, AO
    Laurent, GJ
    Chambers, RC
    THORAX, 2001, 56 : 5 - 5
  • [48] Membrane lipid peroxidation (MLP) in Alzheimer's (AD) and Parkinson's (PD) brains and role of protease-activated receptor-1 (PAR-1).
    Ameenuddin, JS
    Landis, M
    SantaCruz, KS
    Festoff, BW
    JOURNAL OF NEUROCHEMISTRY, 2000, 74 : S17 - S17
  • [49] Vorapaxar: a novel protease-activated receptor-1 inhibitor
    Gurbel, Paul A.
    Jeong, Young-Hoon
    Tantry, Udaya S.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (10) : 1445 - 1453
  • [50] Role of Protease-Activated Receptor-1 in Glioma Growth
    Xie, Qing
    Bao, Xuhui
    Chen, Zhan Hong
    Xu, Ying
    Keep, Richard F.
    Muraszko, Karin M.
    Xi, Guohua
    Hua, Ya
    BRAIN EDEMA XVI: TRANSLATE BASIC SCIENCE INTO CLINICAL PRACTICE, 2016, 121 : 355 - 360